739 related articles for article (PubMed ID: 22089420)
41. Comparative Investigation of Single Voxel Magnetic Resonance Spectroscopy and Dynamic Contrast Enhancement MR Imaging in Differentiation of Benign and Malignant Breast Lesions in a Sample of Iranian Women.
Faeghi F; Baniasadipour B; Jalalshokouhi J
Asian Pac J Cancer Prev; 2015; 16(18):8335-8. PubMed ID: 26745081
[TBL] [Abstract][Full Text] [Related]
42. Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumors.
Herminghaus S; Pilatus U; Möller-Hartmann W; Raab P; Lanfermann H; Schlote W; Zanella FE
NMR Biomed; 2002 Oct; 15(6):385-92. PubMed ID: 12357552
[TBL] [Abstract][Full Text] [Related]
43. Choline metabolic profiling by magnetic resonance spectroscopy.
Iorio E; Ricci A; Pisanu ME; Bagnoli M; Podo F; Canevari S
Methods Mol Biol; 2013; 1049():255-70. PubMed ID: 23913222
[TBL] [Abstract][Full Text] [Related]
44.
Andrejeva G; Gowan S; Lin G; Wong Te Fong AL; Shamsaei E; Parkes HG; Mui J; Raynaud FI; Asad Y; Vizcay-Barrena G; Nikitorowicz-Buniak J; Valenti M; Howell L; Fleck RA; Martin LA; Kirkin V; Leach MO; Chung YL
Autophagy; 2020 Jun; 16(6):1044-1060. PubMed ID: 31517566
[TBL] [Abstract][Full Text] [Related]
45. Role of phospholipase A(2) on the variations of the choline signal intensity observed by 1H magnetic resonance spectroscopy in brain diseases.
Boulanger Y; Labelle M; Khiat A
Brain Res Brain Res Rev; 2000 Sep; 33(2-3):380-9. PubMed ID: 11011072
[TBL] [Abstract][Full Text] [Related]
46. Tumour phospholipid metabolism.
Podo F
NMR Biomed; 1999 Nov; 12(7):413-39. PubMed ID: 10654290
[TBL] [Abstract][Full Text] [Related]
47. Cancer metabolism in a snapshot: MRS(I).
Julià-Sapé M; Candiota AP; Arús C
NMR Biomed; 2019 Oct; 32(10):e4054. PubMed ID: 30633389
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of breast cancer using proton MR spectroscopy: total choline peak integral and signal-to-noise ratio as prognostic indicators.
Shin HJ; Baek HM; Cha JH; Kim HH
AJR Am J Roentgenol; 2012 May; 198(5):W488-97. PubMed ID: 22528931
[TBL] [Abstract][Full Text] [Related]
49. RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation.
Glunde K; Raman V; Mori N; Bhujwalla ZM
Cancer Res; 2005 Dec; 65(23):11034-43. PubMed ID: 16322253
[TBL] [Abstract][Full Text] [Related]
50. Metabolism of phosphonium choline by rat-2 fibroblasts: effects of mitogenic stimulation studied using 31P NMR spectroscopy.
Aiken NR; Szwergold ES; Kappler F; Stoyanova R; Kuesel AC; Shaller C; Brown TR
Anticancer Res; 1996; 16(3B):1357-63. PubMed ID: 8694502
[TBL] [Abstract][Full Text] [Related]
51. Lecithin and choline in human health and disease.
Canty DJ; Zeisel SH
Nutr Rev; 1994 Oct; 52(10):327-39. PubMed ID: 7816350
[TBL] [Abstract][Full Text] [Related]
52. Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer.
Granata A; Nicoletti R; Tinaglia V; De Cecco L; Pisanu ME; Ricci A; Podo F; Canevari S; Iorio E; Bagnoli M; Mezzanzanica D
Br J Cancer; 2014 Jan; 110(2):330-40. PubMed ID: 24281000
[TBL] [Abstract][Full Text] [Related]
53. Lactate and choline metabolites detected in vitro by nuclear magnetic resonance spectroscopy are potential metabolic biomarkers for PI3K inhibition in pediatric glioblastoma.
Al-Saffar NM; Marshall LV; Jackson LE; Balarajah G; Eykyn TR; Agliano A; Clarke PA; Jones C; Workman P; Pearson AD; Leach MO
PLoS One; 2014; 9(8):e103835. PubMed ID: 25084455
[TBL] [Abstract][Full Text] [Related]
54. Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy.
Shino A; Nakasu S; Matsuda M; Handa J; Morikawa S; Inubushi T
J Neurosurg; 1999 Dec; 91(6):928-34. PubMed ID: 10584837
[TBL] [Abstract][Full Text] [Related]
55. In vivo 1H MRS choline: correlation with in vitro chemistry/histology.
Miller BL; Chang L; Booth R; Ernst T; Cornford M; Nikas D; McBride D; Jenden DJ
Life Sci; 1996; 58(22):1929-35. PubMed ID: 8637421
[TBL] [Abstract][Full Text] [Related]
56. Choline Metabolism Alteration: A Focus on Ovarian Cancer.
Bagnoli M; Granata A; Nicoletti R; Krishnamachary B; Bhujwalla ZM; Canese R; Podo F; Canevari S; Iorio E; Mezzanzanica D
Front Oncol; 2016; 6():153. PubMed ID: 27446799
[TBL] [Abstract][Full Text] [Related]
57. Choline kinase as a link connecting phospholipid metabolism and cell cycle regulation: implications in cancer therapy.
Ramírez de Molina A; Gallego-Ortega D; Sarmentero-Estrada J; Lagares D; Gómez Del Pulgar T; Bandrés E; García-Foncillas J; Lacal JC
Int J Biochem Cell Biol; 2008; 40(9):1753-63. PubMed ID: 18296102
[TBL] [Abstract][Full Text] [Related]
58. Prostate and lymph node proton magnetic resonance (MR) spectroscopic imaging with external array coils at 3 T to detect recurrent prostate cancer after radiation therapy.
Heijmink SW; Scheenen TW; Fütterer JJ; Klomp DW; Heesakkers RA; Hulsbergen-van de Kaa CA; van Lin EN; Heerschap A; Barentsz JO
Invest Radiol; 2007 Jun; 42(6):420-7. PubMed ID: 17507814
[TBL] [Abstract][Full Text] [Related]
59. Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy.
Kvistad KA; Bakken IJ; Gribbestad IS; Ehrnholm B; Lundgren S; Fjøsne HE; Haraldseth O
J Magn Reson Imaging; 1999 Aug; 10(2):159-64. PubMed ID: 10441019
[TBL] [Abstract][Full Text] [Related]
60. Choline phospholipids: signal transduction and carcinogenesis.
Zeisel SH
FASEB J; 1993 Apr; 7(6):551-7. PubMed ID: 8472893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
